Vasculitis

 

Study Questions Value of Plasma Exchange for Vasculitis

March 24, 2020

Despite the publication of previous clinical trials that showed plasma exchange could possibly be a viable treatment for patients with severe ANCA-associated vasculitis, a new study recently published in the New England Journal of Medicine shows the treatment, in combination with standard therapy, didn't improve outcomes for patients or lower fatality rates or slow the progression to end-stage kidney disease.

FDA Approves New Treatment for Rare Pediatric Vasculitis

October 01, 2019

The U.S. Food and Drug Administration has approved rituximab (Rituxan, Genentech) for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children 2 years of age and older in combination with glucocorticoids.

EULAR Updates Guidelines for Large Vessel Vasculitis

July 19, 2019

The European League Against Rheumatism has updated treatment guidelines for the management of large vessel vasculitis. Among the changes, the task force no longer recommends the routine use of antiplatelet or anticoagulant therapy. Learn more in this slideshow.